Sun Pharma Indirect Arm To Acquire Thallion Pharmaceuticals

Sun Pharmaceutical Industries today said an indirect arm of its group firm Taro will fully acquire Canada's Thallion Pharmaceuticals for 2.7 million Canadian dollar.

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More